The DropJune 30, 2026via MIT Technology Review
Claude Science is Anthropic’s newest flagship product
Why it matters
Anthropic is moving beyond model releases into vertical-specific application products. Claude Science targets biotech/pharma R&D as a new revenue lever and differentiation point against OpenAI's horizontal approach.
Key signals
- Claude Science announced at pharmaceutical/biotech executive event
- Positioned as flagship product for scientific research support
- Autonomous capability for high-level scientific instructions
- Direct parallel to Claude Code's software engineering use case
- Target verticals: pharmaceutical, biotech, research institutions
The hook
Anthropic just shipped Claude Science. It's not a model update—it's a $X/month product that autonomously runs scientific workflows, same way Claude Code handles engineering.
At an event for pharmaceutical executives, biotech founders, and researchers on Tuesday, Anthropic announced Claude Science, a major new product intended to support scientific research in the same way that Claude Code supports software engineering. Like Claude Code, Claude Science can autonomously carry out meaningful work when given concise, high-level instructions, and it has access…